|
1
|
Yap TA, Lorente D, Omlin A, Olmos D and de
Bono JS: Circulating tumor cells: A multifunctional biomarker. Clin
Cancer Res. 20:2553–2568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Magbanua MJ, Carey LA, DeLuca A, Hwang J,
Scott JH, Rimawi MF, Mayer EL, Marcom PK, Liu MC, Esteva FJ, et al:
Circulating tumor cell analysis in metastatic triple-negative
breast cancers. Clin Cancer Res. 21:1098–1105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cristofanilli M, Budd GT, Ellis MJ,
Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ,
Terstappen LW and Hayes DF: Circulating tumor cells, disease
progression, and survival in metastatic breast cancer. N Engl J
Med. 351:781–791. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cohen SJ, Punt CJ, Iannotti N, Saidman BH,
Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, et
al: Relationship of circulating tumor cells to tumor response,
progression-free survival, and overall survival in patients with
metastatic colorectal cancer. J Clin Oncol. 26:3213–3221. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Scher HI, Heller G, Molina A, Attard G,
Danila DC, Jia X, Peng W, Sandhu SK, Olmos D, Riisnaes R, et al:
Circulating tumor cell biomarker panel as an individual-level
surrogate for survival in metastatic castration-resistant prostate
cancer. J Clin Oncol. 33:1348–1355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rhim AD, Mirek ET, Aiello NM, Maitra A,
Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK,
Vonderheide RH, et al: EMT and dissemination precede pancreatic
tumor formation. Cell. 148:349–361. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sheng Y, Wang T, Li H, Zhang Z, Chen J, He
C, Li Y, Lv Y, Zhang J, Xu C, et al: Comparison of analytic
performances of Cellsearch and iFISH approach in detecting
circulating tumor cells. Oncotarget. 8:8801–8806. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao Y, Zhu Y, Zhang Z, Zhang C, Huang X
and Yuan Z: Clinical significance of pancreatic circulating tumor
cells using combined negative enrichment and
immunostaining-fluorescence in situ hybridization. J Exp Clin
Cancer Res. 35:662016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu W, Zhang Z, Gao XH, Shen Z, Jing Y, Lu
H, Li H, Yang X, Cui X, Li Y, et al: Clinical significance of
detecting circulating tumor cells in colorectal cancer using
subtraction enrichment and immunostaining-fluorescence in situ
hybridization (SE-iFISH). Oncotarget. 8:21639–21649.
2017.PubMed/NCBI
|
|
10
|
Li Y, Zhang X, Ge S, Gao J, Gong J, Lu M,
Zhang Q, Cao Y, Wang DD, Lin PP and Shen L: Clinical significance
of phenotyping and karyotyping of circulating tumor cells in
patients with advanced gastric cancer. Oncotarget. 5:6594–6602.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ilie M, Hofman V, Long-Mira E, Selva E,
Vignaud JM, Padovani B, Mouroux J, Marquette CH and Hofman P:
‘Sentinel’ circulating tumor cells allow early diagnosis of lung
cancer in patients with chronic obstructive pulmonary disease. PLoS
One. 9:e1115972014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ge F, Zhang H, Wang DD, Li L and Lin PP:
Enhanced detection and comprehensive in situ phenotypic
characterization of circulating and disseminated heteroploid
epithelial and glioma tumor cells. Oncotarget. 6:27049–27064. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Wang F, Ning N, Chen Q, Yang Z,
Guo Y, Xu D, Zhang D, Zhan T and Cui W: Patterns of circulating
tumor cells identified by CEP8, CK and CD45 in pancreatic cancer.
Int J Cancer. 136:1228–1233. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Li S, Liu F, Zhou L, Shao N and
Zhao X: SELEX aptamer used as a probe to detect circulating tumor
cells in peripheral blood of pancreatic cancer patients. PLoS One.
10:e01219202015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hyman NH, Anderson P and Blasyk H:
Hyperplastic polyposis and the risk of colorectal cancer. Dis Colon
Rectum. 47:2101–2104. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goldstein NS, Bhanot P, Odish E and Hunter
S: Hyperplastic-like colon polyps that preceded
microsatellite-unstable adenocarcinomas. Am J Clin Pathol.
119:778–796. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jass JR, Young J and Leggett BA:
Hyperplastic polyps and DNA microsatellite unstable cancers of the
colorectum. Histopathology. 37:295–301. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jass JR: Serrated route to colorectal
cancer: Back street or super highway? J Pathol. 193:283–285. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iino H, Jass JR, Simms LA, Young J,
Leggett B, Ajioka Y and Watanabe H: DNA microsatellite instability
in hyperplastic polyps, serrated adenomas, and mixed polyps: A mild
mutator pathway for colorectal cancer? J Clin Pathol. 52:5–9. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Carethers JM and Jung BH: Genetics and
genetic biomarkers in sporadic colorectal cancer. Gastroenterology.
149(1177–1190): e32015.
|
|
22
|
Krebs MG, Metcalf RL, Carter L, Brady G,
Blackhall FH and Dive C: Molecular analysis of circulating tumour
cells-biology and biomarkers. Nat Rev Clin Oncol. 11:129–144. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shaukat A, Mongin SJ, Geisser MS, Lederle
FA, Bond JH, Mandel JS and Church TR: Long-term mortality after
screening for colorectal cancer. N Engl J Med. 369:1106–1114. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lohr JG, Adalsteinsson VA, Cibulskis K,
Choudhury AD, Rosenberg M, Cruz-Gordillo P, Francis JM, Zhang CZ,
Shalek AK, Satija R, et al: Whole-exome sequencing of circulating
tumor cells provides a window into metastatic prostate cancer. Nat
Biotechnol. 32:479–484. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Faugeroux V, Lefebvre C, Pailler E,
Pierron V, Billiot F, Marcaaillou C, Tourlet S, Vielh P, Dogan S,
Rameau P, et al: Whole-exome sequencing of single circulating tumor
cells is a useful tool for studying the intrapatient genetic
heterogeneity in metastatic prostate cancer. J Clin Oncol. 35 6
Suppl:S1482017. View Article : Google Scholar
|
